Siena, Italy and Nottingham, UK — 13 January 2020 — (Life Science Newswire) — Exosomics SpA, the leading extracellular vesicles biotech company, today announced that it has implemented NanoFCM Co., ...
Over the recent years, LNPs have paved new possibilities in the world of nanomedicine. From early stage research to clinical manufacturing, having accurate and comprehensive characterisation of LNPs ...
Exosomics SpA, the leading extracellular vesicles biotech company, today announced that it has implemented NanoFCM Co., Ltd’s NanoAnalyzer instrument to offer sophisticated contract research and ...
As CAR-T therapies continue to evolve, both viral and non-viral delivery systems are emerging as powerful platforms for nucleic acid delivery and cellular engineering. However, the successful ...
(MENAFN- EIN Presswire) The in-depth knowledge and expertise in EV characterization provided by RoosterBio will allow new and existing EV platforms to thrive in this exciting field.” - Ben Peacock, ...
NanoFCM Co., Ltd. announced that it has established a new facility to support existing and potential users of its Nano-Flow Cytometry platform. The Centre of Excellence is located in Medicity, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results